Published: May 24, 2026 | Category: Virology & Vaccine Research The World Health Organization declared the current Ebola outbreak in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern (PHEIC) on May 17, 2026....
Share this post:
Published: May 12, 2026 | Category: Virology & Vaccine Research As the global health community responds to the ongoing Andes virus outbreak aboard a cruise ship in the Atlantic Ocean, researchers and diagnostic developers need reliable tools to advance detection...
Share this post:
Share this post:
× ⚠️ Current Outbreak Status (January 2026) A small, contained cluster of 2 confirmed cases (both 25-year-old nurses at the same private hospital in Barasat) has been reported. Symptoms began late December 2025; confirmed Jan 13, 2026. One patient remains...
Share this post:
Biosimilars have become indispensable tools in modern laboratory research. While widely recognized for their therapeutic impact, biosimilar monoclonal antibodies (mAbs) also play a critical role behind the scenes — helping researchers explore new biological pathways, evaluate assay performance, and accelerate...
Share this post:
When Connectomics scientists set out to find a better way map neural connections with nanoscale precision, they faced an obstacle: no existing antibodies for some of their protein tags So they turned to ProSci. In a groundbreaking preprint on bioRxiv—“Combinatorial...
Share this post:
Why RUO Antibodies Matter in Process Development Process development is the bridge between early discovery and clinical manufacturing. At this critical stage, teams must characterize molecules, monitor quality, and establish reproducible assays that will scale into regulated environments. Reliable antibodies...
Share this post:
In the world of antibody development, delivering reliable, high-performance reagents isn’t just a goal—it’s a commitment. At ProSci LLC, that commitment is embodied through a foundation of robust quality control (QC) across every phase of antibody production, ensuring researchers receive...
Share this post:
Compliance note: All ProSci products and services are for Research Use Only (RUO). Not for use in diagnostic or therapeutic procedures. Antibodies are more than just reagents—they are the backbone of modern biology and therapeutic discovery. Whether you’re validating a...
Share this post:
In the race to bring new antibody-drug conjugates (ADCs) to market, one challenge often slows even the most promising programs: detecting and characterizing novel payloads. When no commercial anti-payload antibodies exist — and the payload structure itself is new to...
Share this post:
